Search

Author/Creator Sewell, Christina

1. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Issue 11 (6th November 2022)

Authors:
Desai, Milind Y.; Owens, Anjali; Geske, Jeffrey B.; Wolski, Kathy; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C.; Naidu, Srihari S.; Smedira, Nicholas G.; Schaff, Hartzell; McErlean, Ellen; Sewell, Christina; Balasubramanyam, Aarthi; Lampl, Kathy; Sehnert, Amy J.; Nissen, Steven E.
Journal:
Circulation
Issue:
Volume 147:Issue 11(2023)
Page Start:
850
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. (June 2021)

Authors:
Cremer, Paul C; Abbate, Antonio; Hudock, Kristin; McWilliams, Carla; Mehta, Jinesh; Chang, Steven Y; Sheng, Calvin C; Van Tassell, Benjamin; Bonaventura, Aldo; Vecchié, Alessandra; Carey, Brenna; Wang, Qiuqing; Wolski, Katherine E; Rajendram, Prabalini; Duggal, Abhijit; Wang, Tisha S; Paolini, Jo...
Journal:
Lancet
Issue:
Volume 3:Number 6(2021)
Page Start:
e410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search